SBC Medical Group (NASDAQ:SBC) Stock Price Up 1.7% - Still a Buy?

Key Points

• SBC Medical Group (NASDAQ:SBC) stock rose 1.7% to $4.23, with trading volume significantly down at around 34,465 shares, compared to an average of 65,056 shares.
• Analyst ratings are mixed, with Weiss Ratings giving it a "sell (d+)" while Wall Street Zen recently upgraded the stock from "hold" to "buy".
• The company's latest earnings report showed a miss in earnings per share at $0.02 compared to the expected $0.14, alongside a revenue of $43.36 million, both below analyst expectations.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report) rose 1.7% during trading on Wednesday . The stock traded as high as $4.29 and last traded at $4.23. Approximately 34,465 shares changed hands during mid-day trading, a decline of 47% from the average daily volume of 65,056 shares. The stock had previously closed at $4.16.

Wall Street Analyst Weigh In

SBC has been the topic of several research reports. Weiss Ratings restated a "sell (d+)" rating on shares of SBC Medical Group in a report on Tuesday. Wall Street Zen upgraded shares of SBC Medical Group from a "hold" rating to a "buy" rating in a report on Saturday, September 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of "Sell".

SBC Medical Group Price Performance

The company has a debt-to-equity ratio of 0.03, a current ratio of 3.98 and a quick ratio of 3.95. The company's 50-day simple moving average is $4.29 and its 200-day simple moving average is $4.22. The company has a market cap of $439.41 million, a price-to-earnings ratio of 13.22 and a beta of 1.29.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last issued its quarterly earnings data on Wednesday, August 13th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The firm had revenue of $43.36 million during the quarter, compared to analyst estimates of $44.71 million. On average, equities research analysts anticipate that SBC Medical Group Holdings Incorporated will post 5.02 EPS for the current year.

Hedge Funds Weigh In On SBC Medical Group

Several institutional investors and hedge funds have recently made changes to their positions in SBC. XTX Topco Ltd purchased a new position in shares of SBC Medical Group during the 2nd quarter valued at approximately $64,000. New York State Common Retirement Fund purchased a new position in shares of SBC Medical Group during the 2nd quarter valued at approximately $104,000. SBI Securities Co. Ltd. boosted its stake in shares of SBC Medical Group by 227.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock valued at $251,000 after buying an additional 37,623 shares during the last quarter. Finally, Geode Capital Management LLC purchased a new position in shares of SBC Medical Group during the 2nd quarter valued at approximately $455,000. 60.82% of the stock is currently owned by hedge funds and other institutional investors.

SBC Medical Group Company Profile

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.